US FDA approves first prescription-free iPhone blood glucose monitor

According to news on March 6, the U.S. Food and Drug Administration (FDA) approved Dexcom’s Stelo glucose biosensor system. The system can be connected to an iPhone via Bluetooth and can be purchased without a doctor’s prescription. This is the first time the FDA has approved this system. class equipment.

The FDA said the device is not intended for people who have been diagnosed with hypoglycemia or are receiving insulin, and such patients will still need to use a prescription device. The device is suitable for people with non-insulin-dependent diabetes and anyone who may be at risk of developing diabetes. It is understood that the system consists of wearable sensors and a smartphone application that can automatically measure, record, analyze and display blood glucose values ​​every 15 minutes, and each sensor can be worn for up to 15 days before replacement. The approval of the device is significant because it will allow more people to conveniently monitor blood sugar, improve access to care, and bring health management into the home environment, the FDA said. Dexcom says the device will go on sale in the United States this summer. It is worth mentioning that non-invasive blood glucose monitoring is still the ultimate goal in the medical field. Reports emerged last year that Apple initially planned to include the feature in the Apple Watch, but it failed to materialize due to technical limitations. The FDA has also warned people not to use any non-invasive blood glucose monitoring products because they are unreliable. To be sure, non-invasive blood glucose monitoring is still the long-term development goal of major manufacturers. Apple Watch may also integrate this feature in the future, but it will take some time at present.

The above is the detailed content of US FDA approves first prescription-free iPhone blood glucose monitor. For more information, please follow other related articles on the PHP Chinese website!